Procept Biorobotics Corp (PRCT) Stock Price, Quote & News

Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 232 7200

Website: www.procept-biorobotics.com

Address:

150 Baytech Drive, San Jose, United States

_GoldenTradingg Dec. 4 at 11:54 PM

SNSE IS SQUEEZING!!! $W $PRCT $CGC $AREC $SLDP .

0 · Reply

Iightning Dec. 4 at 10:36 PM

1ightning® Premium Options Alert (Actionable) Ticker: $PRCT Contract: Dec 19 $37.5C Entry: 0.82 Exit: 1.06 Return: +28.09% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

GoldensLairsTrading Dec. 4 at 10:14 PM

SNSE will SQUEEZE DON'T OVERLOOK IT!! $CTOR $BB $RKT $MNDR $PRCT ;;;

1 · Reply

__GoldenSteers Dec. 4 at 9:00 PM

SNSE will SQUEEZE DON'T OVERLOOK IT!! $SMJF $SPCE $MBOT $PRCT $CTOR

0 · Reply

Iightning Dec. 4 at 6:16 AM

1ightning® Premium Options Alert (Actionable) Ticker: $PRCT Contract: Dec 19 $35C Entry: 1.15 Exit: 1.81 Return: +57.31% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 3 at 10:01 AM

1ightning® Premium Options Alert (Actionable) Ticker: $PRCT Contract: Dec 19 $25C Entry: 4.90 Exit: 6.61 Return: +34.95% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

JarvisFlow Dec. 2 at 5:52 PM

Morgan Stanley updates rating for PROCEPT BioRobotics ( $PRCT ) to Overweight, target set at 56 → 51.

0 · Reply

Iightning Dec. 2 at 12:33 AM

**1ightning® Premium Options Alert (Actionable)** **Ticker:** $PRCT **Contract:** Dec 19 $32.5C **Entry:** 1.15 **Exit:** 1.63 **Return:** **+42.02% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**

0 · Reply

Oruveek70 Dec. 1 at 12:00 PM

$PRCT a quiet message stream. 🤔

0 · Reply

Iightning Nov. 26 at 3:25 AM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $32 Call | Enter: $0.95 Exit: $1.49 | Profit: 56.94% ROI | https://1ightning.com

0 · Reply

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

Nov 20, 2025, 8:40 AM EST - 14 days ago

Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits

BA BFAM CWAN EPS EW LSCC MOD

Nov 4, 2025, 9:36 PM EST - 4 weeks ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:03 PM EST - 4 weeks ago

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

Oct 29, 2025, 9:00 AM EDT - 5 weeks ago

2 Robotics Stocks Riding the Sensor and Medical Boom

OUST

Oct 24, 2025, 12:39 AM EDT - 5 weeks ago

Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?

Oct 15, 2025, 4:03 PM EDT - 7 weeks ago

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 6, 2025, 12:30 PM EDT - 2 months ago

Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader

Aug 14, 2025, 5:24 PM EDT - 4 months ago

Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy

Aug 7, 2025, 2:17 AM EDT - 4 months ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 8:32 PM EDT - 4 months ago

Procept (PRCT) Q2 Revenue Jumps 48%

Aug 6, 2025, 5:35 PM EDT - 4 months ago

PROCEPT BioRobotics (PRCT) Earnings Transcript

Aug 6, 2025, 4:03 PM EDT - 4 months ago

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Jul 24, 2025, 6:00 PM EDT - 4 months ago

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

Jul 23, 2025, 8:00 AM EDT - 4 months ago

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

Jul 21, 2025, 4:03 PM EDT - 4 months ago

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 14, 2025, 9:15 PM EDT - 5 months ago

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

May 17, 2025, 7:00 AM EDT - 7 months ago

19 stocks at the intersection of AI and robotics that could see big sales boosts

AI AMBA CLS HSAI IOT ISRG NOW

Apr 29, 2025, 4:03 PM EDT - 7 months ago

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

Apr 24, 2025, 4:03 PM EDT - 8 months ago

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

Apr 24, 2025, 2:37 PM EDT - 8 months ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 7:00 AM EDT - 8 months ago

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Apr 10, 2025, 4:03 PM EDT - 8 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Mar 24, 2025, 8:00 AM EDT - 9 months ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

Mar 14, 2025, 8:00 AM EDT - 9 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Mar 11, 2025, 4:42 AM EDT - 9 months ago

Procept BioRobotics: Strong Growth, But Profitability Seems Far Away

Feb 25, 2025, 4:02 PM EST - 10 months ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

Feb 7, 2025, 8:00 AM EST - 10 months ago

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Jan 16, 2025, 9:00 AM EST - 11 months ago

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

Nov 26, 2024, 4:05 PM EST - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Nov 26, 2024, 5:10 AM EST - 1 year ago

Procept BioRobotics: Continued Growth Runway Ahead

Oct 29, 2024, 8:43 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

Oct 28, 2024, 4:19 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

Oct 28, 2024, 2:17 PM EDT - 1 year ago

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

Oct 28, 2024, 10:32 AM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Oct 9, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

Oct 7, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

Aug 28, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Aug 27, 2024, 8:30 AM EDT - 1 year ago

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

Aug 21, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Aug 3, 2024, 9:23 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

Jul 15, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

Jun 17, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

Jun 3, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

May 13, 2024, 4:05 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

May 6, 2024, 8:00 AM EDT - 1 year ago

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 1, 2024, 12:56 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript

May 1, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

_GoldenTradingg Dec. 4 at 11:54 PM

SNSE IS SQUEEZING!!! $W $PRCT $CGC $AREC $SLDP .

0 · Reply

Iightning Dec. 4 at 10:36 PM

1ightning® Premium Options Alert (Actionable) Ticker: $PRCT Contract: Dec 19 $37.5C Entry: 0.82 Exit: 1.06 Return: +28.09% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

GoldensLairsTrading Dec. 4 at 10:14 PM

SNSE will SQUEEZE DON'T OVERLOOK IT!! $CTOR $BB $RKT $MNDR $PRCT ;;;

1 · Reply

__GoldenSteers Dec. 4 at 9:00 PM

SNSE will SQUEEZE DON'T OVERLOOK IT!! $SMJF $SPCE $MBOT $PRCT $CTOR

0 · Reply

Iightning Dec. 4 at 6:16 AM

1ightning® Premium Options Alert (Actionable) Ticker: $PRCT Contract: Dec 19 $35C Entry: 1.15 Exit: 1.81 Return: +57.31% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 3 at 10:01 AM

1ightning® Premium Options Alert (Actionable) Ticker: $PRCT Contract: Dec 19 $25C Entry: 4.90 Exit: 6.61 Return: +34.95% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

JarvisFlow Dec. 2 at 5:52 PM

Morgan Stanley updates rating for PROCEPT BioRobotics ( $PRCT ) to Overweight, target set at 56 → 51.

0 · Reply

Iightning Dec. 2 at 12:33 AM

0 · Reply

Oruveek70 Dec. 1 at 12:00 PM

$PRCT a quiet message stream. 🤔

0 · Reply

Iightning Nov. 26 at 3:25 AM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $32 Call | Enter: $0.95 Exit: $1.49 | Profit: 56.94% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 1:31 PM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $32 Call | Enter: $0.95 Exit: $1.49 | Profit: 56.94% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 2:25 AM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $32 Call | Enter: $0.95 Exit: $1.49 | Profit: 56.94% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 11:40 PM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $30 Call | Enter: $1.89 Exit: $3.45 | Profit: 82.29% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 3:00 AM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $30 Call | Enter: $1.89 Exit: $3.45 | Profit: 82.29% ROI | https://1ightning.com

0 · Reply

TheBoss1956 Nov. 20 at 11:19 PM

$PRCT wow what happened with this one?

1 · Reply

Iightning Nov. 20 at 12:23 AM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $30 Call | Enter: $1.89 Exit: $3.45 | Profit: 82.29% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 8:38 AM

1ightning® Options Trade Alert (Actionable) | Buy $PRCT Dec 19 $30 Call | Enter: $1.89 Exit: $3.45 | Profit: 82.29% ROI | https://1ightning.com

0 · Reply

Alimzade16 Nov. 18 at 8:39 PM

$PRCT still bullish, will come to 50s until eoy

1 · Reply

Oruveek70 Nov. 16 at 11:02 PM

$PRCT 'a niche market' - near to 52 week lows. Robotics in all it's guises: surgical, subsea, nano robotics, AI ..you name it will draw interest as we head towards the end of 2025 and beyond, in my view. Not a recent article attached but got my attention. https://seekingalpha.com/article/4828093-procept-biorobotic-strong-challenger-positioned-to-be-future-leader

0 · Reply

flapinux Nov. 14 at 4:32 PM

$PRCT Check out the analyst price targets on this thing & the chart itself shows strong long term support is mid 20s. Time to build a nice position :)

0 · Reply

WAJeff Nov. 12 at 7:27 PM

$MSTR Easily the worst thing I bought all year. Put it at the top of the loser pile, ahead of even $PRCT

0 · Reply

Reanimated666 Nov. 12 at 7:27 PM

$PRCT Getting juicy under 30

0 · Reply

Market Cap	1.65B
Revenue (ttm)	224.50M
Net Income (ttm)	-91.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40.72%
Debt to Equity Ratio	0.14

Volume	2,377,300
Avg Vol	1,420,516
Day's Range	N/A - N/A
Shares Out	55.88M
Stochastic %K	93%
Beta	0.99
Analysts	Strong Sell
Price Target	$52.10